3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Myeloid
1
Gynecologic
1
Gastrointestinal
1
Endocrine
1
CNS
1
Conditions
Myelodysplastic Syndromes
35
Leukemia
33
Leukemia, Myeloid, Acute
28
Precursor Cell Lymphoblastic Leukemia-Lymphoma
23
Myeloproliferative Disorders
21
Leukemia, Myeloid, Accelerated Phase
18
Congenital Abnormalities
18
Lymphoma, Non-Hodgkin
16
Lymphoma
16
Leukemia, Myelomonocytic, Chronic
16
Leukemia, Myeloid, Chronic-Phase
16
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
16
Blast Crisis
16
Anemia, Refractory, with Excess of Blasts
16
Myelodysplastic-Myeloproliferative Diseases
15
Multiple Myeloma
13
Lymphoma, Large B-Cell, Diffuse
13
Primary Myelofibrosis
12
Lymphoma, Mantle-Cell
12
Leukemia, Lymphocytic, Chronic, B-Cell
12
Burkitt Lymphoma
12
Neoplasms, Plasma Cell
11
Lymphoma, Large-Cell, Immunoblastic
11
Lymphoma, Follicular
11
Lymphoma, B-Cell, Marginal Zone
10
Hodgkin Disease
10
Dendritic Cell Sarcoma, Interdigitating
8
Polycythemia Vera
7
Pdgfra-Associated Chronic Eosinophilic Leukemia
7
Lymphohistiocytosis, Hemophagocytic
7
Interventions
etoposide phosphate
1
Sirolimus
1
LMB-100
1
Etoposide
1
Cytoreduction Surgical Procedures
1
Cyclophosphamide
1
Celecoxib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Carcinoma
×
Etoposide
×
Myeloid
×
Clear all
NCT02574728
2026-03-02
AflacST1502
Emory University
Phase 2
Active not recruiting
46 enrolled